Exhibit Partners, LLC – Trademark Portfolio
Entity Type: 16
Exhibit Partners, LLC holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 3 filings in this category. The portfolio also extends into Class 37 (Building & Construction) across 4 Nice Classification classes. Currently, 1 trademark is registered and 2 are pending. Notable registered marks include STORYLINK. The owner is based in Maple Grove, MN.
10100 85th Avenue North
Maple Grove, MN 55369
Showing of trademarks Trademarks
Trademark Classifications
Exhibit Partners, LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Exhibit Partners, LLC have?
Exhibit Partners, LLC has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 pending.
What trademark classes does Exhibit Partners, LLC file in?
Exhibit Partners, LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 37 (Building & Construction), Class 42 (Computer & Scientific), Class 41 (Education & Entertainment). Class 35 covers advertising; business management; business administration; office functions.
What are Exhibit Partners, LLC's most well-known trademarks?
Exhibit Partners, LLC's registered trademark portfolio includes well-known marks such as STORYLINK. These are among 1 currently registered trademark in the portfolio.
What is Exhibit Partners, LLC's trademark registration success rate?
Exhibit Partners, LLC has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 2 applications are pending review.